anaboliclondon.com
No products in the cart.
Return To Shopanaboliclondon.com
No products in the cart.
Return To Shop€21.00
Atorlip 5 mg Cipla is a lipid-lowering medication primarily composed of Atorvastatin as its active ingredient. This statin works by inhibiting HMG-CoA reductase, an enzyme crucial for the biosynthesis of cholesterol in the liver. The reduction in cholesterol synthesis leads to an increase in hepatic uptake of low-density lipoprotein (LDL) from the bloodstream, ultimately lowering LDL levels.
– Active Ingredient: Atorvastatin
– Dosage: 5 mg
– Manufacturer: Cipla
This potent compound plays an essential role in promoting cardiovascular health and managing lipid levels, making it a valuable asset for athletes who prioritize optimal performance and recovery.
Athletes often engage in intense training regimens, necessitating tools to enhance performance and recovery. Atorlip 5 mg Cipla can contribute to improved physical performance through its ability to manage cholesterol levels and promote overall heart health. Maintaining optimal cardiovascular function is crucial for endurance athletes, as it supports efficient oxygen transport throughout the body.
Furthermore, a well-functioning cardiovascular system improves nutrient delivery to muscles during training sessions, which can result in better muscle adaptation and faster recovery times. These effects can be particularly advantageous during intensive training phases, where muscle repair and energy replenishment are critical. Athletes may notice increased stamina, enhanced muscle recovery, and an overall boost in training effectiveness, allowing for a more robust adaptation to their training stimuli.
Purchasing Atorlip 5 mg Cipla online provides convenience and accessibility for athletes looking to enhance their performance. Our online store offers a user-friendly experience, ensuring that you can easily find and purchase Atorlip 5 mg Cipla without hassle.
Advantages of our store include:
Whether you are preparing for a competition or seeking to maintain optimal health during your training, our store ensures you receive high-quality products, including Atorlip 5 mg Cipla, delivered directly to your doorstep.
When considering the use of Atorlip 5 mg Cipla, it is essential to follow a structured cycle tailored to your training goals. An optimal cycle duration generally ranges between 4 to 12 weeks. It is advisable to consult with a healthcare provider before commencing the use of any medication, including Atorlip.
Beginning the cycle ideally coincides with the onset of an intensified training phase. For example, starting Atorlip at the beginning of a competitive training period allows for the maximum benefits concerning energy, recovery, and muscle adaptation. Evaluating your body’s response to the medication can help determine the appropriate time to conclude the cycle, but stopping after 12 weeks is recommended unless advised otherwise.
While Atorlip 5 mg Cipla is generally well-tolerated, some adverse effects may occur. It is critical for athletes to consider these potential risks before incorporating this medication into their regimen.
Possible adverse effects include:
It is also important to observe essential precautions when using Atorlip. Regular monitoring of liver function is advised, especially if used for extended periods. Athletes should communicate any existing health conditions or ongoing medications with their healthcare provider to ensure safe usage. Individual responses may vary, and being aware of these factors will help in making informed decisions regarding performance enhancement and recovery strategies.
| Active substance | Atorvastatin |
|---|---|
| Water Retention | No |
| Hepatotoxicity | Possible, particularly at higher doses |
| Lab Test | Liver function tests, lipid panel |
| Strength | 5mg |
| Also known as | Lipitor |
| Blood pressure | Can potentially lower blood pressure |
| Trade name | Lipitor |
| Storage conditions | Store at room temperature away from moisture, heat, and light |
| Chemical name | (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid |
| Formula | C33H35FN2O5 |
| Substance class | Statin |
| Main action | Cholesterol-lowering by inhibiting HMG-CoA reductase |
| Half-life | 14 hours |
| Dosage (medical) | 10-80 mg daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces levels of bad cholesterol and triglycerides in the blood while increasing levels of good cholesterol |
| Side effects | Muscle pain, increased liver enzymes, diarrhea, joint pain, memory loss or confusion |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 10 tabs/blister |
€22.00
€27.00
Reviews
There are no reviews yet.